0,989  0,002  Chemoprotective
0,966  0,002  Monophenol monooxygenase inhibitor
0,953  0,001  UGT1A9 substrate
0,947  0,001  Melanin inhibitor
0,949  0,003  TNF expression inhibitor
0,943  0,002  Antihypercholesterolemic
0,942  0,001  Antimutagenic
0,939  0,002  NOS2 expression inhibitor
0,929  0,003  Chemopreventive
0,911  0,003  Genotoxic
0,902  0,001  Amylase inhibitor
0,896  0,002  UGT1A1 substrate
0,895  0,002  Antihypoxic
0,896  0,008  Alpha-glucosidase inhibitor
0,886  0,004  Caspase 9 stimulant
0,879  0,002  Proliferative diseases treatment
0,880  0,004  Antioxidant
0,879  0,005  Cyclophilin D inhibitor
0,879  0,005  Antidiabetic
0,864  0,009  Transcription factor NF kappa B inhibitor
0,858  0,009  Antiinflammatory
0,825  0,003  Sulfotransferase substrate
0,821  0,002  Xanthine oxidase inhibitor
0,822  0,005  Mutagenic
0,818  0,015  Apoptosis agonist
0,802  0,002  VCAM1 expression inhibitor
0,799  0,004  Cardioprotectant
0,797  0,004  UDP-glucuronosyltransferase substrate
0,797  0,004  Free radical scavenger
0,792  0,004  CYP2C19 substrate
0,788  0,004  Hypoglycemic
0,786  0,010  Teratogen
0,776  0,003  Skin whitener
0,773  0,003  Antitussive
0,766  0,004  NOS3 expression inhibitor
0,766  0,007  Respiratory analeptic
0,756  0,006  Cytostatic
0,738  0,002  Antihemorrhagic
0,740  0,006  Analeptic
0,745  0,012  Embryotoxic
0,733  0,005  Caspase 3 stimulant
0,729  0,002  Expectorant
0,728  0,002  Beta glucuronidase inhibitor
0,732  0,007  Sensitization
0,730  0,010  Carcinogenic
0,720  0,007  Antibacterial
0,714  0,005  Hepatic disorders treatment
0,709  0,005  Nitric oxide antagonist
0,710  0,017  CYP3A4 substrate
0,687  0,005  Vascular (periferal) disease treatment
0,671  0,005  Angiogenesis stimulant
0,672  0,007  Antiparasitic
0,668  0,004  Hepatoprotectant
0,673  0,010  Antithrombotic
0,665  0,005  Apoptosis antagonist
0,649  0,003  Neurotrophic factor enhancer
0,652  0,006  Antipyretic
0,651  0,010  5 Hydroxytryptamine release stimulant
0,647  0,009  Cytotoxic
0,641  0,005  Antihelmintic
0,637  0,005  Antihypertriglyceridemic
0,631  0,006  Antiamyloidogenic
0,635  0,012  CYP1A2 substrate
0,618  0,002  Protein kinase stimulant
0,606  0,004  NOS3 expression enhancer
0,611  0,014  Radioprotector
0,606  0,010  AR expression inhibitor
0,600  0,008  Amyloid beta aggregation inhibitor
0,602  0,010  Histamine release inhibitor
0,596  0,008  Tumour necrosis factor alpha release inhibitor
0,593  0,014  Spasmolytic
0,597  0,019  Cholesterol antagonist
0,584  0,013  Antipruritic, allergic
0,577  0,009  DNA damaging
0,597  0,035  Antineoplastic (breast cancer)
0,579  0,027  Antileukemic
0,554  0,005  UGT2B4 substrate
0,553  0,004  Alkylator
0,549  0,005  ICAM1 expression inhibitor
0,553  0,010  Vasodilator, coronary
0,554  0,013  Antineoplastic (brain cancer)
0,551  0,014  Antifungal
0,534  0,005  Antihypotensive
0,549  0,023  Immunostimulant
0,536  0,014  Antidiabetic (type 2)
0,519  0,004  UGT2B15 substrate
0,522  0,010  Antineoplastic (osteosarcoma)
0,533  0,031  Antineoplastic (colorectal cancer)
0,505  0,012  Vasodilator
0,511  0,026  Stroke treatment
0,488  0,003  AMP-activated protein kinase stimulant
0,491  0,009  Antineoplastic (sarcoma)
0,492  0,015  Hypoxia-inducible factor 1 alpha inhibitor
0,506  0,031  Immunosuppressant
0,485  0,014  UGT1A6 substrate
0,483  0,013  Antidiabetic symptomatic
0,511  0,043  Antineoplastic (lung cancer)
0,480  0,012  RNA-directed DNA polymerase inhibitor
0,474  0,006  Platelet adhesion inhibitor
0,478  0,012  Myocardial infarction treatment
0,498  0,034  Antineoplastic (colon cancer)
0,470  0,006  Lipid peroxidase inhibitor
0,495  0,037  CYP2C9 substrate
0,459  0,004  Cystathionine beta-synthase inhibitor
0,465  0,013  Interleukin 2 agonist
0,457  0,005  Antidote
0,454  0,004  Mediator release inhibitor
0,473  0,024  Antiosteoporotic
0,448  0,003  Mucolytic
0,443  0,004  Aldose reductase substrate
0,471  0,033  Bone diseases treatment
0,460  0,026  Antineoplastic (pancreatic cancer)
0,450  0,017  DNA synthesis inhibitor
0,436  0,004  UDP-glucose 4-epimerase inhibitor
0,454  0,027  Antineoplastic (glioma)
0,428  0,003  Antiviral (Influenza B)
0,432  0,009  Interferon gamma antagonist
0,442  0,020  Antineoplastic (lymphoma)
0,459  0,040  Prostate cancer treatment
0,429  0,012  Antiviral (Herpes)
0,420  0,014  Cyclic AMP phosphodiesterase inhibitor
0,422  0,020  Antineoplastic (liver cancer)
0,402  0,004  Cyclooxygenase 3 inhibitor
0,399  0,010  Antiviral (Influenza)
0,397  0,008  Liver fibrosis treatment
0,390  0,004  Nitric-oxide synthase stimulant
0,452  0,068  Alzheimer's disease treatment
0,412  0,028  Antiprotozoal (Leishmania)
0,457  0,076  Antineoplastic (solid tumors)
0,386  0,012  UGT1A3 substrate
0,407  0,035  Antineoplastic (cervical cancer)
0,380  0,011  Topoisomerase II inhibitor
0,429  0,061  5 Hydroxytryptamine release inhibitor
0,370  0,004  Selectin antagonist
0,367  0,004  Carbonic anhydrase XIII inhibitor
0,370  0,008  Diabetic nephropathy treatment
0,369  0,007  Glutathione S-transferase substrate
0,391  0,029  Antineoplastic (glioblastoma multiforme)
0,366  0,007  Topoisomerase I inhibitor
0,363  0,006  Antifungal enhancer
0,399  0,044  Immunomodulator
0,359  0,005  Dementia treatment
0,366  0,014  Antipruritic, non-allergic
0,357  0,005  Vascular dementia treatment
0,351  0,001  Sodium/glucose cotransporter inhibitor
0,360  0,009  Interleukin 6 antagonist
0,391  0,041  Lipoprotein disorders treatment
0,364  0,014  Antineoplastic (squamous cell carcinoma)
0,373  0,024  Antineoplastic enhancer
0,371  0,024  Interleukin agonist
0,386  0,047  Antineoplastic (ovarian cancer)
0,348  0,010  Antidiarrheal
0,365  0,026  Antiulcerative
0,348  0,012  Alpha-N-acetylglucosaminidase inhibitor
0,381  0,045  Antiischemic
0,336  0,005  Carbonic anhydrase III inhibitor
0,336  0,005  Histidine decarboxylase inhibitor
0,389  0,059  Vasodilator, peripheral
0,329  0,005  Estrogen agonist
0,369  0,048  Antineoplastic (melanoma)
0,331  0,013  Hemostatic
0,333  0,015  Peptidyltransferase inhibitor
0,326  0,008  Hexokinase inhibitor
0,325  0,008  Antineoplastic antibiotic
0,321  0,010  Aldehyde dehydrogenase inhibitor
0,333  0,022  Non-steroidal antiinflammatory agent
0,315  0,006  Topoisomerase II alpha inhibitor
0,316  0,009  Psychosexual dysfunction treatment
0,323  0,017  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,310  0,006  Estrogen antagonist
0,311  0,009  Cell wall synthesis inhibitor
0,302  0,014  Cystic fibrosis treatment
0,291  0,004  Photosensitizer
0,316  0,030  Septic shock treatment
0,302  0,018  Antihelmintic (Nematodes)
0,329  0,048  Antineoplastic (non-small cell lung cancer)
0,362  0,083  Atherosclerosis treatment
0,297  0,018  Antineoplastic (gastric cancer)
0,283  0,007  NADH dehydrogenase inhibitor
0,360  0,086  CYP2C19 inhibitor
0,290  0,018  Antiviral (Influenza A)
0,282  0,016  Acute respiratory distress syndrome (ARDS) treatment
0,294  0,030  P-glycoprotein inhibitor
0,327  0,065  Antimycobacterial
0,336  0,076  Angiogenesis inhibitor
0,271  0,013  SULT1A3 substrate
0,272  0,015  Cholesterol synthesis inhibitor
0,260  0,004  Carbonic anhydrase VII inhibitor
0,257  0,001  Sodium/glucose cotransporter 1 inhibitor
0,271  0,016  Insulin secretagoues
0,253  0,001  Sodium/glucose cotransporter 2 inhibitor
0,251  0,004  Estrogen receptor beta agonist
0,254  0,008  Carbonic anhydrase VI inhibitor
0,272  0,026  Antiviral (Hepatitis)
0,252  0,007  Estrogen receptor beta antagonist
0,260  0,015  DNA polymerase I inhibitor
0,271  0,026  Sepsis treatment
0,278  0,035  DNA methylase inhibitor
0,254  0,015  Neuropathy treatment
0,257  0,019  Alkaline phosphatase inhibitor
0,312  0,075  CYP2D6 substrate
0,263  0,027  Protein-tyrosine phosphatase inhibitor
0,241  0,008  Phosphofructokinase-1 inhibitor
0,288  0,057  GST M1-1 substrate
0,249  0,018  Antiprotozoal (Coccidial)
0,268  0,039  DNA methyltransferase I inhibitor
0,243  0,014  Antiviral (Ebola)
0,245  0,019  Carcinogenic, group 1
0,255  0,029  Antineoplastic (carcinoma)
0,237  0,015  Interleukin 4 antagonist
0,254  0,033  Thrombolytic
0,300  0,079  Antineoplastic (small cell lung cancer)
0,258  0,039  UGT2B7 substrate
0,236  0,019  Protein-tyrosine phosphatase 1B inhibitor
0,232  0,017  Mannose-6-phosphate isomerase inhibitor
0,221  0,007  Postmenopausal disorders treatment
0,221  0,011  Antibiotic
0,219  0,009  Triose-phosphate isomerase inhibitor
0,271  0,063  Platelet antagonist
0,232  0,025  Antidiabetic (type 1)
0,267  0,060  Hypolipemic
0,220  0,013  Choleretic
0,214  0,007  DNA repair enzyme inhibitor
0,210  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,210  0,004  Phosphodiesterase 6D inhibitor
0,208  0,003  Antibiotic Glycopeptide-like
0,208  0,005  Toll-Like receptor 4 antagonist
0,307  0,104  Ulceration
0,212  0,011  Antihelmintic (Trematoda)
0,207  0,009  Carcinogenic, group 2A
0,206  0,010  Creatine kinase inhibitor
0,266  0,070  Antineoplastic (renal cancer)
0,203  0,007  Aldose reductase inhibitor
0,244  0,049  Antialcoholic
0,210  0,017  Antifungal (Cryptococcus)
0,259  0,078  Radiosensitizer
0,202  0,021  CF transmembrane conductance regulator agonist
0,219  0,038  Hair growth stimulant
0,194  0,014  Gastritis treatment
0,194  0,015  Antineoplastic, alkylator
0,205  0,027  Antiviral (Hepatitis B)
0,201  0,024  Cell adhesion inhibitor
0,188  0,015  Antispirochetal
0,189  0,018  UGT2B1 substrate
0,171  0,002  Cholesterol absorption inhibitor
0,250  0,081  5 Hydroxytryptamine uptake stimulant
0,182  0,015  Antineoplastic (uterine cancer)
0,193  0,028  DNA intercalator
0,201  0,036  ATPase inhibitor
0,259  0,098  Metabolic disease treatment
0,170  0,008  Interleukin 12 antagonist
0,218  0,057  Insulin sensitizer
0,194  0,035  Acetylcholinesterase inhibitor
0,174  0,017  Uric acid excretion stimulant
0,164  0,007  Histone deacetylase SIRT1 stimulant
0,164  0,007  Histone deacetylase stimulant
0,175  0,018  HDL-cholesterol increasing
0,167  0,013  Thioredoxin inhibitor
0,169  0,018  Multidrug resistance-associated protein 1 inhibitor
0,154  0,004  Alpha-mannosidase inhibitor
0,171  0,022  Constipation treatment
0,162  0,015  NAD(P)H dehydrogenase (quinone) inhibitor
0,174  0,027  Microtubule formation inhibitor
0,148  0,006  Na+ K+ transporting ATPase inhibitor
0,250  0,109  CTGF expression inhibitor
0,155  0,014  SULT1E1 substrate
0,145  0,004  Mannosidase inhibitor
0,152  0,015  Transcription factor NF kappa B stimulant
0,189  0,052  Antirickettsial
0,150  0,015  Antiviral (SARS coronavirus)
0,150  0,015  Antiviral (Coronavirus)
0,205  0,070  Sedative
0,142  0,009  Antiviral (Dengue virus)
0,235  0,101  CYP1A2 inhibitor
0,185  0,053  Antiviral (Hepatitis C)
0,137  0,005  Estrogen receptor alpha agonist
0,176  0,045  Cyclooxygenase 1 inhibitor
0,232  0,100  Huntington's disease treatment
0,160  0,034  Beta amyloid protein antagonist
0,230  0,105  Gastrin inhibitor
0,136  0,013  Lipase inhibitor
0,145  0,022  Alcohol dehydrogenase inhibitor
0,181  0,057  Restenosis treatment
0,130  0,008  Neuraminidase inhibitor
0,155  0,036  Heat shock protein 70 antagonist
0,134  0,017  Ornithine decarboxylase inhibitor
0,153  0,039  Gout treatment
0,152  0,038  Carcinogenic, group 2B
0,153  0,039  Growth stimulant
0,124  0,011  Neuraminidase (influenza) inhibitor
0,123  0,011  Narcotic antagonist
0,227  0,115  Antineoplastic (multiple myeloma)
0,147  0,041  Vanilloid 1 agonist
0,187  0,082  Anesthetic general
0,144  0,040  Papain-like protease (SARS coronavirus) inhibitor
0,183  0,079  Wound healing agent
0,192  0,089  Interleukin antagonist
0,120  0,017  Interferon agonist
0,258  0,156  Antiprotozoal
0,114  0,012  Xanthine dehydrogenase inhibitor
0,188  0,087  Psychostimulant
0,109  0,009  Fatty acid synthase inhibitor
0,109  0,010  Antimycoplasmal
0,214  0,115  Antineoplastic (bladder cancer)
0,121  0,023  Interleukin 5 antagonist
0,099  0,003  Antibiotic Aminoglycoside-like
0,156  0,060  Hearing loss treatment
0,101  0,006  Glucose-6-phosphate translocase inhibitor
0,099  0,005  Glucose-6-phosphate isomerase inhibitor
0,116  0,022  ATPase (Vacuolar H+) inhibitor
0,105  0,012  Protein 50S ribosomal subunit inhibitor
0,151  0,061  Adenylate cyclase stimulant
0,112  0,023  Glycine receptor antagonist
0,164  0,075  Muscular dystrophy treatment
0,127  0,038  Chronic obstructive bronchitis treatment
0,192  0,104  Antineoplastic (lymphocytic leukemia)
0,092  0,004  Arginase inhibitor
0,122  0,038  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,103  0,019  Carbonic anhydrase XII inhibitor
0,087  0,004  Protein 30S ribosomal subunit inhibitor
0,101  0,019  Phosphodiesterase VI inhibitor
0,094  0,014  Phosphorylase inhibitor
0,095  0,015  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,097  0,018  Antitreponemal
0,091  0,013  Carbonic anhydrase XIV inhibitor
0,142  0,067  Ca2+-transporting ATPase inhibitor
0,125  0,049  Chelator
0,103  0,029  Antiviral (Hepatitis A)
0,154  0,081  Uterine stimulant
0,116  0,044  Sphingomyelinase inhibitor
0,136  0,065  NADPH oxidase inhibitor
0,077  0,008  Heparanase inhibitor
0,198  0,129  Antituberculosic
0,096  0,029  Estrogen receptor alpha antagonist
0,083  0,022  Protein kinase C eta inhibitor
0,108  0,048  Breast cancer-resistant protein inhibitor
0,089  0,030  HIV-1 integrase (3'-Processing) inhibitor
0,075  0,018  Ca(v)3.2 blocker
0,092  0,034  T cell inhibitor
0,175  0,119  Antiviral (HIV)
0,129  0,073  Antiacne
0,106  0,050  UGT2B11 substrate
0,124  0,073  MAO inhibitor
0,060  0,012  Neuraminidase (Influenza A) inhibitor
0,138  0,090  Eye irritation, high
0,075  0,028  Interferon inducer
0,074  0,029  Nitric oxide donor
0,137  0,093  UGT2B9 substrate
0,061  0,018  Equilibrative nucleoside transport protein inhibitor
0,046  0,003  Vanilloid 2 agonist
0,097  0,055  Antiviral (Rhinovirus)
0,129  0,089  Cyclooxygenase inhibitor
0,101  0,060  Anticataract
0,073  0,034  HIV-1 integrase (Strand Transfer) inhibitor
0,116  0,078  Contraceptive female
0,140  0,106  Dual specificity phosphatase 3 inhibitor
0,117  0,083  Retinoprotector
0,183  0,150  Antineurogenic pain
0,091  0,058  Actinic keratosis treatment
0,218  0,189  Antiobesity
0,053  0,024  Microtubule stabilization
0,127  0,099  Cholinergic
0,030  0,003  Telomerase stimulant
0,060  0,035  Lipocortins synthesis agonist
0,056  0,033  Leukotriene B4 antagonist
0,142  0,118  UGT2B10 substrate
0,082  0,060  Antiviral (Trachoma)
0,026  0,004  Antibiotic Anthracycline-like
0,062  0,040  Aromatase inhibitor
0,100  0,079  SULT1A1 substrate
0,081  0,060  Thioredoxin reductase inhibitor
0,062  0,041  Antidote, heavy metal
0,038  0,018  Tubulin agonist
0,031  0,011  Toll-Like receptor 4 agonist
0,142  0,123  Phospholipase C inhibitor
0,057  0,038  Postcoital contraceptive
0,103  0,084  Carcinogenic, group 3
0,045  0,028  Opioid kappa receptor agonist
0,093  0,077  Carbonic anhydrase XV inhibitor
0,030  0,015  1,3-Beta-glucan synthase inhibitor
0,055  0,041  Adenine nucleotide translocase inhibitor
0,085  0,071  Paget's disease treatment
0,110  0,098  Antibacterial (Helicobacter pylori)
0,049  0,037  Factor III inhibitor
0,026  0,015  Adenosine A1 receptor agonist
0,032  0,022  Nucleoside transporters inhibitor
0,085  0,076  Glutamate release inhibitor
0,141  0,132  Antineoplastic (bone cancer)
0,032  0,023  Estrogen-related receptor beta antagonist
0,028  0,020  Uridine phosphorylase inhibitor
0,101  0,093  Antiviral (CMV)
0,114  0,106  Neurotrophic factor
0,022  0,015  GRP78 expression inhibitor
0,046  0,041  Antiviral (Herpesvirus 3, Human)
0,069  0,064  SULT1A2 substrate
0,022  0,017  Dopamine D1 agonist
0,104  0,100  Contraceptive
0,103  0,100  Cyclooxygenase 2 inhibitor
0,040  0,040  Adenosine deaminase inhibitor
0,044  0,044  Topoisomerase II beta inhibitor
0,009  0,009  Purinergic P2Y2 agonist

